HLN Earnings Date: Mar 4, 2027 (Estimated) — Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
XNYS
Updated
When is HLN's next earnings date?
Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN) is expected to report FY 2026 earnings on Thursday, March 4, 2027 at 4:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.55 on revenue of $15.10B.
How did HLN do in its last earnings report?
In its most recent report on Jul 30, 2026 (H1 2026), Haleon plc American Depositary Shares (Each representing two Ordinary Shares) posted EPS of $0.14 versus the $0.27 estimate, a miss of 48.3%. Revenue was $7.53B against a $3.60B estimate. The stock's 1-day post-earnings move was -1.7%.
How much does HLN stock move after earnings?
HLN beat EPS estimates in 1 of its last 4 reported quarters. Over the last 7 reports the stock moved an average of 3.3% (up or down) in the day after earnings.
About Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-30 | H1 2026 | 0.27 | 0.14 | -48.30% | $7.53B | ❌ Miss | -1.66% | -3.25% | -1.76% |
| 2026-02-26 | FY 2025 | — | 0.25 | — | $14.54B | ❌ Miss | +3.13% | +0.29% | -6.57% |
| 2025-02-27 | FY 2024 | — | 0.23 | — | $14.36B | — | -4.03% | +3.36% | -0.79% |
| 2024-08-01 | H1 2024 | — | 0.11 | — | $7.18B | — | +1.97% | +5.03% | +10.88% |
| 2024-02-29 | FY 2023 | 0.45 | 0.22 | -51.11% | $14.05B | ❌ Miss | +6.20% | +3.34% | +6.64% |
| 2023-08-02 | H1 2023 | — | 0.10 | — | $7.06B | — | -2.68% | -1.64% | -2.30% |
| 2023-03-02 | FY 2022 | — | 0.23 | — | $13.46B | — | -3.66% | -1.63% | +2.81% |
| 2022-11-10 | 0.10 | 0.11 | — | $3.38B | ✅ Beat | — | — | — |
Showing last 8 quarters.